Avian flu now reported in 6 states; Oculus partners with SLA to launch skin products; Virbac charts double-digit growth from Sentinel acquisition;

> The avian flu has been confirmed at an Iowa turkey farm and a Wisconsin chicken farm, bringing the number of states affected to 6. Article

> Oculus Innovative Sciences ($OCLS) partnered with SLA Brands to launch its MicrocynAH line of wound-care products for farm animals. Release

> Virbac announced that its first-quarter sales grew 17% year-over-year, driven by its acquisition of the Sentinel products from Novartis ($NVS). Release

> The FDA alerted pet owners and veterinarians that there is a high risk of illness and death in animals exposed to flurbiprofen, a topical nonsteroidal anti-inflammatory drug (NSAID) used by people. Release

> Vétoquinol announced that sales grew 11% in the first quarter, including currency gains, due largely to 36% growth in the Americas. Release

> The USDA is launching its third national equine study, designed to provide veterinarians and the horse industry with information about current health issues. Article

> Trading in shares of China Animal Healthcare was suspended on the Hong Kong exchange due to the company's delay in reporting its 2014 earnings. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…